drugset / Trial / NCT00332319

Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients

NCT00332319

Phase 2 Terminated 1 enrolled GlaxoSmithKline
RandomizedCrossoverDouble-blindTreatment

Summary

This is a two-part study in which Part A will assess the effects of GW679769 after 1 dose on the function of the nerves that supply the bladder. The technique for measuring the nerves function is called Neurometry. Part B will assess the effect of repeat doses of GW679769 on the bladder nerve function. Part B will also assess the effects of the drug on overactive bladder symptoms using a three-day patient diary.

Timeline

Start
2006-01
Primary completion
2007-02
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Casopitant Small molecule 120 mg
Subject Casopitant Small molecule 150 mg

Indications